Literature DB >> 19880574

Pathogenic role of anti-endothelial cell antibodies in autoimmune rheumatic diseases.

D S Domiciano1, J F Carvalho, Y Shoenfeld.   

Abstract

Anti-endothelial cells antibodies have been detected in numerous autoimmune and inflammatory diseases, including systemic lupus erythematous, rheumatoid arthritis, vasculitis and sarcoidosis. Anti-endothelial cells antibodies bind to endothelial cell antigens and induce endothelial damage. Their effects on the endothelial cell have been considered responsible, at least in part, by the vascular injury which occurs in these pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19880574     DOI: 10.1177/0961203309346654

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  13 in total

1.  Peroxiredoxin 2 is a novel autoantigen for anti-endothelial cell antibodies in systemic vasculitis.

Authors:  R Karasawa; M S Kurokawa; K Yudoh; K Masuko; S Ozaki; T Kato
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

2.  Autoantibodies against myelin sheath and S100β are associated with cognitive dysfunction in patients with rheumatoid arthritis.

Authors:  Talita Siara Almeida Baptista; Laura Esteves Petersen; Julia K Molina; Tatiana de Nardi; Andréa Wieck; Aline do Prado; Deise Marcela Piovesan; Mauro Keisermann; Rodrigo Grassi-Oliveira; Moisés Evandro Bauer
Journal:  Clin Rheumatol       Date:  2017-06-27       Impact factor: 2.980

3.  The Level of IgA Antibodies to Endothelial Cells Correlates with Histological Evidence of Disease Activity in Patients with Lupus Nephritis.

Authors:  Ayako Kondo; Kazuo Takahashi; Tomohiro Mizuno; Akihiro Kato; Daisuke Hirano; Naoki Yamamoto; Hiroki Hayashi; Shigehisa Koide; Hiroshi Takahashi; Midori Hasegawa; Yoshiyuki Hiki; Shunji Yoshida; Keiji Miura; Yukio Yuzawa
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

4.  Autoantibodies to endothelial cell surface ATP synthase, the endogenous receptor for hsp60, might play a pathogenic role in vasculatides.

Authors:  Jean-Eric Alard; Sophie Hillion; Loïc Guillevin; Alain Saraux; Jacques-Olivier Pers; Pierre Youinou; Christophe Jamin
Journal:  PLoS One       Date:  2011-02-07       Impact factor: 3.240

Review 5.  The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus.

Authors:  J Michelle Kahlenberg; Mariana J Kaplan
Journal:  Arthritis Res Ther       Date:  2011-02-28       Impact factor: 5.156

6.  Identification of target antigens of anti-endothelial cell and anti-vascular smooth muscle cell antibodies in patients with giant cell arteritis: a proteomic approach.

Authors:  Alexis Régent; Hanadi Dib; Kim H Ly; Christian Agard; Mathieu C Tamby; Nicolas Tamas; Babette Weksler; Christian Federici; Cédric Broussard; Loïc Guillevin; Luc Mouthon
Journal:  Arthritis Res Ther       Date:  2011-06-28       Impact factor: 5.156

Review 7.  Pulmonary arterial hypertension in systemic lupus erythematosus: current status and future direction.

Authors:  Atiya Dhala
Journal:  Clin Dev Immunol       Date:  2012-03-22

8.  Identification of Ocular Autoantigens Associated With Juvenile Idiopathic Arthritis-Associated Uveitis.

Authors:  Martin Busch; Kira Leona Wefelmeyer; Karoline Walscheid; Kai Rothaus; Dirk Bauer; Cornelia A Deeg; Roxane L Degroote; Doreen Ackermann; Simone König; Solon Thanos; Maren Kasper; Arnd Heiligenhaus
Journal:  Front Immunol       Date:  2019-08-06       Impact factor: 7.561

Review 9.  Vasculitis, Autoimmunity, and Cytokines: How the Immune System Can Harm the Brain.

Authors:  Alessandra Tesser; Alessia Pin; Elisabetta Mencaroni; Virginia Gulino; Alberto Tommasini
Journal:  Int J Environ Res Public Health       Date:  2021-05-24       Impact factor: 3.390

10.  Anti-endothelial cell antibodies do not correlate with disease activity in systemic sclerosis.

Authors:  Małgorzata Michalska-Jakubus; Małgorzata Kowal; Michał Adamczyk; Dorota Krasowska
Journal:  Postepy Dermatol Alergol       Date:  2018-04-24       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.